I Shahar
Overview
Explore the profile of I Shahar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarid O, Slonim-Nevo V, Pereg A, Friger M, Sergienko R, Schwartz D, et al.
PLoS One
. 2017 Mar;
12(2):e0172779.
PMID: 28245260
Objective: To identify coping strategies and socio-demographics impacting satisfaction with life and quality of life in Crohn's disease (CD). Methods: 402 patients completed the Patient Harvey-Bradshaw Index, Brief COPE Inventory,...
2.
Inzelberg R, Plotnik M, Flash T, Schechtman E, Shahar I, Korczyn A
J Mot Behav
. 2001 Dec;
33(4):377-85.
PMID: 11734412
Switching difficulties in Parkinson's disease (PD) are expressed in both mental and motor tasks. The authors of the present study investigated whether those deficits coexist in the same patient and...
3.
Fireman E, Shahar I, Shoval S, Messer G, Dvash S, Grief J
Lung
. 2001 Dec;
179(2):105-17.
PMID: 11733853
The phenotype of alveolar-associated fibroblasts (Afb) in sarcoidosis (SA) and idiopathic pulmonary fibrosis (IPF) is unclear. In the present study, we characterized the cytoskeletal proteins and the contraction properties in...
4.
Shahar I, Fireman E, Topilsky M, Grief J, Schwarz Y, Kivity S, et al.
Int J Immunopharmacol
. 1999 Nov;
21(11):759-75.
PMID: 10576621
Endothelin-1 (ET-1) is a potent constrictor and mitogen peptide which is expressed in several pulmonary diseases. To elucidate the involvement of ET-1 in lung interstitial pathologic events, we assessed ET-1...
5.
Fireman E, Kivity S, Shahar I, Reshef T, Mekori Y
Immunol Lett
. 1999 Jun;
67(3):229-36.
PMID: 10369131
Sarcoidosis (SA) and diffuse interstitial fibrosis (DIF) are characterized by alveolitis, mast cell hyperplasia and increased fibroblast proliferation. Stem cell factor (SCF) stimulates proliferation of hematopoietic progenitor cells involved in...
6.
Shahar I, Fireman E, Topilsky M, Grief J, Kivity S, Spirer Z, et al.
Clin Immunol Immunopathol
. 1996 Jun;
79(3):244-51.
PMID: 8635282
Alveolar macrophage-fibroblast interaction may be involved in the pathogenesis of interstitial lung diseases (ILD). Herein, we compared IL-6 secretion from alveolar macrophages (AM) and alveolar fibroblasts (AFb) recovered from patients...
7.
Inzelberg R, Plotnik M, Flash T, Schechtman E, Shahar I, Korczyn A
Adv Neurol
. 1996 Jan;
69:361-9.
PMID: 8615152
No abstract available.
8.
Zakay D, Tsal Y, Moses M, Shahar I
Mem Cognit
. 1994 May;
22(3):344-51.
PMID: 8007836
In five experiments, we investigated the effects of the segmentation level of an interval on its perceived duration. A prospective paradigm and an absolute time estimation method were used in...
9.
Wollman Y, Shahar I, Goldstein M, Leibovici J
J Neurooncol
. 1994 Jan;
19(2):123-9.
PMID: 7964987
The main cause for the failure of chemotherapeutic treatment of advanced cancer probably lies in the emergence of drug resistance clones. In the present study we compared the sensitivity to...